This site is intended for Healthcare Professionals only.

England dispensed 1.11 billion prescription items in 2020-21

Date:

Share post:

The cost of prescription items dispensed in England in 2020-21 was £9.61 billion, a 3.49 per cent increase of £324 million from £9.28 billion in the previous year.

“This is the second consecutive year that the cost of items dispensed in England has increased following three consecutive years of decreases between 2015-16 and 2018-19,” the NHS Business Services Authority (NHSBSA) said as it published its annual prescription cost analysis (PCA) today (June 10).

The number of prescription items dispensed was 1.11 billion, a 1.90 per cent decrease of 21.5 million items from 1.13 billion in 2019-20.

Atorvastatin, a ‘statin’ mainly used in lowering cholesterol in people suffering from high blood cholesterol or in prevention of heart disease, was found to be the most dispensed drug in England in 2020-21 with 49.9 million items.

Apixaban, an anticoagulant to prevent blood clots, was the drug with highest cost of £356 million.

Sertraline 100 mg (an antidepressant) tablet was the presentation with the “largest increase in cost between 2019-20 and 2020-21 of £78.9 million, from £21.0 million to £99.9 million.”

As per the analysis, the cost of Sertraline increased by 376 per cent between 2019-20 and 2020-21, while the number of items prescribed increased by 7.51 per cent.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Pharmacy First vital to amplify NHS digital prescription rollout, WHO report reveals

75 per cent of adults in England are registered for digital prescriptions on the NHS App In a groundbreaking...

Haleon to close Maidenhead manufacturing site affecting 435 jobs

Despite the closure, Haleon will retain its presence in the UK with corporate offices in Weybridge and London Haleon,...

UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro amidst escalating competition

Obesity experts raise concern that retail marketing of weight-loss drugs could trivialise their side-effects   British pharmacies and slimming...

MHRA says many online pharmacies are ‘unregulated’,’ illegal’, or ‘fraudulent’

MHRA's latest initiative aims to empower consumers in the fight against online pharmacy frauds The Medicines and Healthcare products...